Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul-Dec;23(6):597-606.
doi: 10.1080/14737167.2023.2203384. Epub 2023 Apr 17.

Tackling reimbursement challenges to fair access to medicines - introduction to the topic

Affiliations
Review

Tackling reimbursement challenges to fair access to medicines - introduction to the topic

Konstantin Tachkov et al. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec.

Abstract

Introduction: Ensuring both financial and physical access to medicines is a challenge for the reimbursement system. How countries are currently tackling this challenge is an issue worth exploring in this review paper.

Areas covered: The review covered three areas of studies such as pricing, reimbursement, and patient access measures. We compared the use and shortcomings of all measures influencing patients' access to medicines.

Expert opinion: In this work, we tried attempted to outline fair access policies toward reimbursed medicines in a historical manner by researching the measures accepted during different time periods by governments that affect patient access. From the review, it is evident that the countries are following similar models with a focus on pricing measures, reimbursement measures, and measures directly affecting the patients. It is our opinion that most of the measures are focused on ensuring the sustainability of the payer's funds and less are those that stimulate faster access. Even worse, we found that studies that are measuring the real patients access, and affordability are scarce.

Keywords: Patient access; health technology assessment; managed entry agreements; medicines; pricing; reference pricing; reimbursement.

PubMed Disclaimer

LinkOut - more resources